Skip to content

Baxter International BAX Renal — Net Revenue

Discontinued — last reported Q3 '17

Similar metrics at other companies

DaVita logo
DVAU.S. dialysis — Total revenue net of intersegment revenue
$2.83B+4.3%
DaVita logo
DVAU S Dialysis — Total revenues
$2.81B+2.9%
Zimmer Biomet Holdings logo
ZBHOperating Segments — Product Revenue
$979.3M+1.0%
DaVita logo
DVAUS Dialysis And Related Lab Services — Health Care Organization Revenue
$2.52B+11.5%
Regal Rexnord logo
RRXOperating Segments — Product Revenue
$904M+7.8%
DaVita logo
DVAOther - Ancillary Services — Revenue
$494.32M+20.0%

Other financials

Income statement

See full
Revenue$2.7B+2.9%
Gross profit$891.0M+3.5%
Operating income$66.0M+13.8%
Net income-$15.0M-112%
EPS (diluted)-$0.03-112%

Balance sheet

See full
Cash & equivalents$2.0B-12.1%
Total debt$224.0M-8.9%
Total equity$6.0B-14.7%
Total assets$19.8B-6.8%

Cash flow

See full
Operating cash flow$213.0M+210%
CapEx$128.3M+15.0%
Free cash flow$83.0M-42.1%

Valuation

See full
Market cap$10.27B-50.6%
Enterprise value$8.48B-55.6%
P/S0.9×-1.0×

Profitability

See full
Gross margin30.1%-5.9pp
Operating margin-2.7%
Net margin-9.7%+62.5pp
FCF margin3%-2.4pp

Returns & leverage

See full
Return on equity-16.7%-76.7pp
Debt / equity0.0×
Current ratio1.9×-0.2×

Where this comes from

Reported directly by Baxter International in its filing.

Tagged under the XBRL concept us-gaap:SalesRevenueNet.

The official record: Baxter International’s 10-Q, filed November 2, 2017, on SEC EDGAR. View the filing →

Questions, answered.

What does renal — net revenue mean?
Total net sales generated by the Renal business segment.
How do you interpret renal — net revenue?
Higher revenue indicates strong market demand and successful commercial execution for kidney care products.
How does renal — net revenue compare across companies?
A core metric for comparing the scale and growth trajectory of renal care divisions across medical device competitors.